Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 6, 2010, Pages 2604-2609

  Kanashiro Takeuchi, Rosemeire M ^a   Tziomalos, Konstantinos ^a   Takeuchi, Lauro M ^a   Treuer, Adriana V ^a   Lamirault, Guillaume ^a   Dulce, Raul ^a   Hurtado, Michael ^a   Song, Yun ^a   Block, Norman L ^a,b   Rick, Ferenc ^a,b   Klukovits, Anna ^a,b   Hu, Qinghua ^a   Varga, Jozsef L ^a,b   Schally, Andrew V ^a,b   Hare, Joshua M ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Cardiac stem cells; Heart failure; Remodeling

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE DERIVATIVE; GROWTH HORMONE RELEASING HORMONE AGONIST; JI 38; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DIVISION; CELL PROLIFERATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; GENE EXPRESSION; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; HEART PROTECTION; HEART WEIGHT; HEMODYNAMICS; HISTOPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; WEIGHT GAIN;

ANIMALS; BLOTTING, WESTERN; BODY WEIGHT; CARDIOTONIC AGENTS; ECHOCARDIOGRAPHY; FEMALE; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; HEART; HEMODYNAMICS; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR I; MYOCARDIAL INFARCTION; MYOCARDIUM; ORGAN SIZE; RANDOM ALLOCATION; RATS; RATS, INBRED F344; RECEPTORS, NEUROPEPTIDE; RECEPTORS, PITUITARY HORMONE-REGULATING HORMONE; RECOMBINANT PROTEINS;

RATTUS;

EID: 77249162694     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0914138107     Document Type: Article

References (40)

1. Fazio S, Palmieri EA, Biondi B, Cittadini A, Saccà L (2000) The role of the GH-IGF-I axis in the regulation of myocardial growth: From experimental models to human evidence. Eur J Endocrinol 142:211-216.
2. Cittadini A, et al. (2001) Importance of an intact growth hormone/insulin-like growth factor 1 axis for normal post-infarction healing: Studies in dwarf rats. Endocrinology 142:332-338.
3. Fazio S, et al. (1996) A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med 334:809-814.
4. Osterziel KJ, et al. (1998) Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet 351:1233-1237.
5. Cittadini A, et al. (1997) Growth hormone attenuates early left ventricular remodeling and improves cardiac function in rats with large myocardial infarction. J Am Coll Cardiol 29:1109-1116.
6. Tivesten A, et al. (2000) The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction. Endocrinology 141:60-66.
7. Broglio F, et al. (2002) Ghrelin: Much more than a natural growth hormone secretagogue. Isr Med Assoc J 4:607-613.
8. Marleau S, Mulumba M, Lamontagne D, Ong H (2006) Cardiac and peripheral actions of growth hormone and its releasing peptides: Relevance for the treatment of cardiomyopathies. Cardiovasc Res 69:26-35.
9. Matsubara S, Sato M, Mizobuchi M, Niimi M, Takahara J (1995) Differential gene expression of growth hormone (GH)-releasing hormone (GRH) and GRH receptor in various rat tissues. Endocrinology 136:4147-4150.
10. Granata R, et al. (2009) Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart. Cardiovasc Res 83:303-312.
11. Aimaretti G, et al. (2004) GHRH and GH secretagogues: Clinical perspectives and safety. Pediatr Endocrinol Rev 2 (Suppl 1):86-92.
12. Kiaris H, Schally AV, Kalofoutis A (2005) Extrapituitary effects of the growth hormone-releasing hormone. Vitam Horm 70:1-24.
13. Izdebski J, et al. (1995) Synthesis and biological evaluation of superactive agonists of growth hormone-releasing hormone. Proc Natl Acad Sci USA 92:4872-4876.
14. Cittadini A, et al. (2003) Growth hormone prolongs survival in experimental postinfarction heart failure. J Am Coll Cardiol 41:2154-2163.
15. Pagel I, et al. (2002) Cardiac and renal effects of growth hormone in volume overload-induced heart failure: role of NO. Hypertension 39:57-62.
16. Bollano E, et al. (2001) Growth hormone alone or combined with metoprolol preserves cardiac function after myocardial infarction in rats. Eur J Heart Fail 3:651-660.
17. Omerovic E, et al. (2000) Growth hormone improves bioenergetics and decreases catecholamines in postinfarct rat hearts. Endocrinology 141:4592-4599.
18. Mill JG, et al. (2005) [The early administration of growth hormone results in deleterious effects on ventricular remodeling after acute myocardial infarction]. Arq Bras Cardiol 84:115-121.
19. Shen YT, Wiedmann RT, Lynch JJ, Grossman W, Johnson RG (1996) GH replacement fails to improve ventricular function in hypophysectomized rats with myocardial infarction. Am J Physiol 271:H1721-H1727.
20. Tivesten A, et al. (2001) Similar cardiovascular effects of growth hormone and insulin-like growth factor-I in rats after experimental myocardial infarction. Growth Horm IGF Res 11:187-195.
21. Isgaard J, et al. (1997) Growth hormone improves cardiac function in rats with experimental myocardial infarction. Eur J Clin Invest 27:517-525.
22. Duerr RL, et al. (1996) Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat. Circulation 93:2188-2196.
23. Jørgensen KD, et al. (1988) Biosynthetic human growth hormone: Subchronic toxicity studies in rats and monkeys. Pharmacol Toxicol 62:329-333.
24. Nagaya N, et al. (2001) Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 104:1430-1435.
25. Frascarelli S, Ghelardoni S, Ronca-Testoni S, Zucchi R (2003) Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart. Basic Res Cardiol 98:401-405.
26. Mayo KE (1992) Molecular cloning and expression of a pituitary-specific receptor for growth hormone-releasing hormone. Mol Endocrinol 6:1734-1744.
27. Pombo CM, Zalvide J, Gaylinn BD, Diéguez C (2000) Growth hormone-releasing hormone stimulates mitogen-activated protein kinase. Endocrinology 141:2113-2119.
28. Baldanzi G, et al. (2002) Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 159:1029-1037.
29. Lorenz K, Schmitt JP, Vidal M, Lohse MJ (2009) Cardiac hypertrophy: Targeting Raf/MEK/ERK1/2-signaling. Int J Biochem Cell Biol 41:2351-2355.
30. Brywe KG, et al. (2005) Growth hormone-releasing peptide hexarelin reduces neonatal brain injury and alters Akt/glycogen synthase kinase-3beta phosphorylation. Endocrinology 146:4665-4672.
31. Shioi T, et al. (2000) The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J 19:2537-2548.
32. Shiojima I, Walsh K (2006) Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Genes Dev 20:3347-3365.
33. Anversa P, Kajstura J (1998) Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res 83:1-14.
34. Bersell K, Arab S, Haring B, Kühn B (2009) Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell 138:257-270.
35. Bergmann O, et al. (2009) Evidence for cardiomyocyte renewal in humans. Science 324:98-102.
36. Brüel A, Christoffersen TE, Nyengaard JR (2007) Growth hormone increases the proliferation of existing cardiac myocytes and the total number of cardiac myocytes in the rat heart. Cardiovasc Res 76:400-408.
37. Fazel S, et al. (2006) Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest 116:1865-1877.
38. Padin-Iruegas ME, et al. (2009) Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction. Circulation 120:876-887.
39. Gonzalez A, et al. (2008) Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan. Circ Res 102:597-606.
40. Kanashiro-Takeuchi RM, et al. (2009) Sex-specific impact of aldosterone receptor antagonism on ventricular remodeling and gene expression after myocardial infarction. Clin Transl Sci 2:134-142.